Search company, investor...

SpectraCure

spectracure.se

Investors Count

4

Funding, Valuation & Revenue

2 Fundings

SpectraCure's latest funding round was a IPO for on June 1, 2015.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/1/2015

IPO

0

FY undefined

1

Other Investors

0

FY undefined

0

Date

6/1/2015

Round

IPO

Other Investors

Amount

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

Sources

1

0

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

SpectraCure Investors

4 Investors

SpectraCure has 4 investors. Teknoseed invested in SpectraCure's Other Investors funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1
Other Investors

Industrifonden

Subscribe to see more

Venture Capital

Sweden

Karolinska Development

Subscribe to see more

Asset/Investment Management

Sweden

Lunds Universitets Innovation System

Subscribe to see more

Academic/University

Sweden

First funding

Last Funding

Investor

Industrifonden

Karolinska Development

Lunds Universitets Innovation System

Rounds

1
Other Investors

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Asset/Investment Management

Academic/University

Location

Sweden

Sweden

Sweden

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.